Helix Biotech

Helix Biotech is a full service CDMO specializing in nucleic acid therapeutics and nanoparticle delivery systems. Our expertise spans mRNA design, synthesis, and optimization, lipid nanoparticle (LNP) and liposomal formulation development, analytical method establishment, and GMP manufacturing.

At the heart of our innovation is the Nova™ Impinged Jet Mixer (IJM) — a scalable, license-free system for rapid and reproducible LNP production, enabling seamless transfer from benchtop to GMP. Through our drug substance (DS) and drug product (DP) service platforms, we deliver end-to-end support, from sequence to vial, helping clients accelerate programs in vaccines, gene therapy, oncology, and cell engineering.

By combining advanced formulation engineering with bioinformatics-driven mRNA optimization, Helix Biotech empowers partners to design, produce, and scale transformative RNA-based medicines with greater performance.